Livzon Pharmaceutical Group Inc (000513) — Cash Flow Reinvestment Rate
Livzon Pharmaceutical Group Inc (000513) has a Cash Flow Reinvestment Rate of 0.44x as of December 2025, reinvesting CN¥276.99 Million (capex CN¥78.72 Million plus investments CN¥-198.26 Million) from operating cash flow of CN¥625.70 Million. Check 000513 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Livzon Pharmaceutical Group Inc Cash Flow Reinvestment Rate (1999–2025)
Historical reinvestment intensity for Livzon Pharmaceutical Group Inc across 27 annual periods. Explore 000513 long-term investments to assets to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Livzon Pharmaceutical Group Inc (1999–2025)
Year-by-year capital reinvestment analysis for Livzon Pharmaceutical Group Inc. For live market cap and broader valuation context, see market cap of Livzon Pharmaceutical Group Inc.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.60x | CN¥1.90 Billion | CN¥3.18 Billion | CN¥574.14 Million | ▲ +171.0% |
| 2024 | 0.22x | CN¥656.96 Million | CN¥2.98 Billion | CN¥570.16 Million | ▼ -53.1% |
| 2023 | 0.47x | CN¥1.53 Billion | CN¥3.25 Billion | CN¥820.45 Million | ▼ -39.9% |
| 2022 | 0.78x | CN¥2.17 Billion | CN¥2.77 Billion | CN¥940.15 Million | ▼ -25.0% |
| 2021 | 1.04x | CN¥1.98 Billion | CN¥1.90 Billion | CN¥1.31 Billion | ▲ +202.3% |
| 2020 | 0.35x | CN¥745.73 Million | CN¥2.16 Billion | CN¥646.98 Million | ▲ +52.6% |
| 2019 | 0.23x | CN¥399.55 Million | CN¥1.77 Billion | CN¥398.00 Million | ▼ -71.3% |
| 2018 | 0.79x | CN¥997.34 Million | CN¥1.27 Billion | CN¥474.47 Million | ▲ +32.8% |
| 2017 | 0.59x | CN¥779.77 Million | CN¥1.32 Billion | CN¥294.15 Million | ▼ -42.2% |
| 2016 | 1.03x | CN¥1.31 Billion | CN¥1.28 Billion | CN¥368.46 Million | ▲ +70.5% |
| 2015 | 0.60x | CN¥557.97 Million | CN¥927.79 Million | CN¥477.13 Million | ▼ -35.2% |
| 2014 | 0.93x | CN¥665.52 Million | CN¥717.39 Million | CN¥665.52 Million | ▼ -55.6% |
| 2013 | 2.09x | CN¥920.00 Million | CN¥439.99 Million | CN¥920.00 Million | ▲ +62.9% |
| 2012 | 1.28x | CN¥762.30 Million | CN¥593.96 Million | CN¥762.30 Million | ▲ +160.6% |
| 2011 | 0.49x | CN¥348.83 Million | CN¥708.20 Million | CN¥348.83 Million | ▼ -7.4% |
| 2010 | 0.53x | CN¥336.95 Million | CN¥633.30 Million | CN¥336.95 Million | ▲ +100.4% |
| 2009 | 0.27x | CN¥131.41 Million | CN¥494.88 Million | CN¥131.41 Million | ▲ +21.4% |
| 2008 | 0.22x | CN¥75.52 Million | CN¥345.18 Million | CN¥75.52 Million | ▼ -40.4% |
| 2007 | 0.37x | CN¥91.28 Million | CN¥248.55 Million | CN¥91.28 Million | ▼ -53.9% |
| 2006 | 0.80x | CN¥180.45 Million | CN¥226.46 Million | CN¥180.45 Million | ▼ -50.0% |
| 2005 | 1.59x | CN¥256.72 Million | CN¥161.07 Million | CN¥256.72 Million | ▲ +97.4% |
| 2004 | 0.81x | CN¥146.48 Million | CN¥181.46 Million | CN¥146.48 Million | ▲ +133.9% |
| 2003 | 0.35x | CN¥103.56 Million | CN¥300.01 Million | CN¥103.56 Million | ▼ -28.8% |
| 2002 | 0.48x | CN¥103.62 Million | CN¥213.65 Million | CN¥103.62 Million | ▼ -7.7% |
| 2001 | 0.53x | CN¥81.48 Million | CN¥155.15 Million | CN¥81.48 Million | ▼ -67.1% |
| 2000 | 1.60x | CN¥61.49 Million | CN¥38.52 Million | CN¥61.49 Million | ▲ +435.3% |
| 1999 | 0.30x | CN¥73.44 Million | CN¥246.23 Million | CN¥73.44 Million | — |